| Symbol | FEMY |
|---|---|
| Name | FEMASYS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 3950 JOHNS CREEK COURT, SUWANEE, GA 30024 |
| Telephone | 770-500-3910 |
| Fax | — |
| — | |
| Website | https://www.femasys.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001339005 |
| Description | Femasys Inc is a biomedical company focused on transforming womens healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The companys mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Additional info from NASDAQ: |
- Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Read moreFemasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Read more(19% Negative) FEMASYS INC (FEMY) Announces Delay in innovations Trials for women worldwide through its broad Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT05977751 | Prospective Multi-Center Trial for FemBloc Permanent Birth Control | Na | Contraception | Recruiting | 2023-10-31 | 2031-06-01 | ClinicalTrials.gov |
| NCT04968847 | FemaSeed LOCAL Artificial Insemination Trial | Na | Infertility | Completed | 2021-07-15 | 2024-04-30 | ClinicalTrials.gov |
| NCT04273594 | FemBloc® Permanent Contraception - Confirmation Feasibility Trial | Na | Contraception | Active_Not_Recruiting | 2020-02-27 | 2027-04-01 | ClinicalTrials.gov |
| NCT03433911 | FemBloc® Permanent Contraception - Early Pivotal Trial | Na | Contraception | Completed | 2018-02-02 | 2025-02-10 | ClinicalTrials.gov |
| NCT03067272 | Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception | Na | Contraception | Completed | 2017-03-15 | 2023-03-14 | ClinicalTrials.gov |
| NCT01053052 | Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG | Na | Fallopian Tube Patency Tests | Withdrawn | 2010-01-01 | 2013-01-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| FemBloc | Other | Approved | Contraception | ACTIVE_NOT_RECRUITING | NCT04273594 |
| Sonography with FemVue, and HSG | Other | Approved | Fallopian Tube Patency Tests | WITHDRAWN | NCT01053052 |
| FemBloc® Permanent Contraceptive System | Other | Approved | Contraception | COMPLETED | NCT03067272 |
| FemaSeed Localized Directional Insemination | Other | Approved | Infertility | COMPLETED | NCT04968847 |
| Laparoscopic bilateral tubal sterilization | Other | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | Other | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | Other | Approved | Contraception | RECRUITING | NCT05977751 |
| FemaSeed Localized Directional Insemination | DEVICE | Approved | Infertility | COMPLETED | NCT04968847 |
| Laparoscopic bilateral tubal sterilization | PROCEDURE | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | DEVICE | Approved | Contraception | RECRUITING | NCT05977751 |
| FemBloc® Permanent Contraceptive System | DEVICE | Approved | Contraception | COMPLETED | NCT03067272 |
| Sonography with FemVue, and HSG | DEVICE | Approved | Fallopian Tube Patency Tests | WITHDRAWN | NCT01053052 |